Variable clinical phenotypes of α-thalassemia syndromes

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 615-625

  Singer, Sylvia Titi ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

globin mutations; thalassemia; Hemoglobin H; Hemoglobin H constant spring

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; DEFERIPRONE; FERRITIN; FOLIC ACID; HEMOGLOBIN; IRON CHELATE; MESSENGER RNA;

ALPHA THALASSEMIA; ANEMIA; BONE MARROW TRANSPLANTATION; CHOLELITHIASIS; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DELETION MUTANT; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSERYTHROPOIESIS; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; ERYTHROCYTOSIS; FERRITIN BLOOD LEVEL; GALLSTONE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE; HEMOGLOBIN BARTS HYDROPS FETALIS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN H CONSTANT SPRING; HEMOGLOBIN H DISEASE; HEPATOMEGALY; HETEROZYGOSITY; HETEROZYGOTE; HETEROZYGOTE DETECTION; HOMOZYGOSITY; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; INTRAVASCULAR HEMOLYSIS; IRON OVERLOAD; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MICROCYTOSIS; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; PRENATAL DISORDER; PRENATAL SCREENING; REVIEW; SPLENOMEGALY; THROMBOCYTOSIS; TREATMENT OUTCOME; CLASSIFICATION; GENETICS; METHODOLOGY; NEWBORN; NEWBORN SCREENING; PHENOTYPE; SYNDROME;

ALPHA-THALASSEMIA; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PHENOTYPE; SYNDROME;

EID: 70349315028     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.69     Document Type: Review

References (66)

1. Chui, D.H. (2005) Alpha-thalassaemia and population health in Southeast Asia. Ann. Hum. Biol. 32, 123-130. (Pubitemid 40995612)
2. Chui, D.H. and Waye, J.S. (1998) Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood 91, 2213-2222.
3. Laig, M., Pape, M., Hundrieser, J., Flatz, G., Sanguansermsri, T., Das, B.M., Deka, R., Yongvanit, P., and Mularlee, N. (1990) The distribution of the Hb constant spring gene in Southeast Asian populations. Hum. Genet. 84, 188-190. (Pubitemid 20043877)
4. Vichinsky, E.P., MacKlin, E.A., Waye, J.S., Lorey, F., and Olivieri, N.F. (2005) Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics 116, e818-825. (Pubitemid 46056461)
5. Lorey, F. and Cunningham, G. (1998) Impact of Asian immigration on thalassemia in California. Ann. N. Y. Acad. Sci. 850, 442-445. (Pubitemid 28369798)
6. Chui, D.H., Fucharoen, S., and Chan, V. (2003) Hemoglobin H disease: not necessarily a benign disorder. Blood 101, 791-800. (Pubitemid 36139341)
7. Schrier, S.L. (1994) Thalassemia: pathophysiology of red cell changes. Annu. Rev. Med. 45, 211-218.
8. Weatherall, D.J., Stamatoyannopoulos, G., Neinhuis, A.W., Majerus, P.W., and Varmus, H. (1994) The Thalassemias. The Molecular Basis of Blood Diseases. W.B. Saunders, Philadelphia. pp. 157-205.
9. Winichagoon, P., Higgs, D.R., Goodbourn, S.E., Clegg, J.B., Weatherall, D.J., and Wasi, P. (1984) The molecular basis of alpha-thalassaemia in Thailand. EMBO J. 3, 1813-1818.
10. Embury, S.H., Miller, J.A., Dozy, A.M., Kan, Y.W., Chan, V., and Todd, D. (1980) Two different molecular organizations account for the single alpha-globin gene of the alpha-thalassemia-2 genotype. J. Clin. Invest. 66, 1319-1325.
11. Winichagoon, P., Fucharoen, S., and Wasi, P. (1992) The molecular basis of alpha-thalassemia in Thailand. Southeast Asian J. Trop. Med. Public Health 23(Suppl 2), 7-13.
12. Chaisue, C., Kitcharoen, S., Wilairat, P., Jetsrisuparb, A., Fucharoen, G., and Fucharoen, S. (2007) alpha/beta-Globin mRNA ratio determination by multiplex quantitative real-time reverse transcription-polymerase chain reaction as an indicator of globin gene function. Clin. Biochem. 40, 1373-1377. (Pubitemid 350151423)
13. Liang, S.T., Wong, V.C., So, W.W., Ma, H.K., Chan, V., and Todd, D. (1985) Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases. Br. J. Obstet. Gynaecol. 92, 680-684. (Pubitemid 15048746)
14. Higgs, D.R., Sharpe, J.A., and Wood, W.G. (1998) Understanding alpha globin gene expression: a step towards effective gene therapy. Semin. Hematol. 35, 93-104.
15. Weatherall, D.J. (2005) Keynote address: the challenge of thalassemia for the developing countries. Ann. N. Y. Acad. Sci. 1054, 11-17. (Pubitemid 43031005)
16. Kan, Y.W., Schwartz, E., and Nathan, D.G. (1969) Globin chain synthesis in the alpha thalassemia syndromes. J. Clin. Invest. 47, 2512-2522.
17. Yuan, J., Bunyaratvej, A., Fucharoen, S., Fung, C., Shinar, E., and Schrier, S.L. (1995) The instability of the membrane skeleton in thalassemic red blood cells. Blood 86, 3945-3950.
18. Schrier, S.L., Rachmilewitz, E., and Mohandas, N. (1989) Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations. Blood 74, 2194-2202. (Pubitemid 19269130)
19. Schrier, S.L., Bunyaratvej, A., Khuhapinant, A., Fucharoen, S., Aljurf, M., Snyder, L.M., Keifer, C.R., Ma, L., and Mohandas, N. (1997) The unusual pathobiology of hemoglobin constant spring red blood cells. Blood 89, 1762-1769. (Pubitemid 27097472)
20. Hardison, R.C., Chui, D.H., Giardine, B., Riemer, C., Patrinos, G.P., Anagnou, N., Miller, W., and Wajcman, H. (2002) HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum. Mutat. 19, 225-233. (Pubitemid 34195183)
21. Higgs, D.R., Pressley, L., Aldridge, B., Clegg, J.B., Weatherall, D.J., Cao, A., Hadjiminas, M.G., Kattamis, C., Metaxatou-Mavromati, A., Rachmilewitz, E.A., and Sophocleous, T. (1981) Genetic and molecular diversity in nondeletion Hb H disease. Proc. Natl. Acad. Sci. U. S. A. 78, 5833-5837. (Pubitemid 12204455)
22. Liebhaber, S.A. and Kan, Y.W. (1983) alpha-Thalassemia caused by an unstable alpha-globin mutant. J. Clin. Invest. 71, 461-466.
23. Jones, C.M., Charache, S., and Hathaway, P.J. (1979) The effect of hemoglobin F-Chesapeake (alpha 2 92 Arg. leads to Leu gamma 2) on fetal oxygen affinity and erythropoiesis. Pediatr. Res. 13, 851-853.
24. Weatherall, D.J., Clegg, J.B., Gibbons, R., Higgs, D.R., Old, J.M., Olivieri, N.F., Thein, S.L., and Wood, W.G. (2001) The Thalassemia Syndromes. Blackwell Science, Oxford.
25. Chan, V.V., Chan, T.K., and Todd, D. (1988) Different forms of Hb H disease in the Chinese. Hemoglobin 12, 499-507.
26. Chen, F.E., Ooi, C., Ha, S.Y., Cheung, B.M., Todd, D., Liang, R., Chan, T.K., and Chan, V. (2000) Genetic and clinical features of hemoglobin H disease in Chinese patients. N. Engl. J. Med. 343, 544-550. (Pubitemid 30650749)
27. Hsu, H.C., Wang, C.C., Peng, H.W., Ho, C.H., and Lin, C.K. (1990) Hemoglobin H disease--ten years' experience. Zhonghua Yi Xue Za Zhi (Taipei) 45, 34-38.
28. Tso, S.C., Chan, T.K., and Todd, D. (1982) Venous thrombosis in haemoglobin H disease after splenectomy. Aust. N. Z. J. Med. 12, 635-638.
29. Tso, S.C., Loh, T.T., and Todd, D. (1984) Iron overload in patients with haemoglobin H disease. Scand. J. Haematol. 32, 391-394. (Pubitemid 14107218)
30. Hsu, H.C., Lin, C.K., Tsay, S.H., Tse, E., Ho, C.H., Chow, M.P., Yung, C.H., and Peng, H.W. (1990) Iron overload in Chinese patients with hemoglobin H disease. Am. J. Hematol. 34, 287-290. (Pubitemid 20223504)
31. Origa, R., Sollaino, M.C., Giagu, N., Barella, S., Campus, S., Mandas, C., Bina, P., Perseu, L., and Galanello, R. (2007) Clinical and molecular analysis of haemoglobin H disease in Sardinia: haematological, obstetric and cardiac aspects in patients with different genotypes. Br. J. Haematol. 136, 326-332. (Pubitemid 46020764)
32. Pootrakul, P., Vongsmasa, V., La-ongpanich, P., and Wasi, P. (1981) Serum ferritin levels in thalassemias and the effect of splenectomy. Acta Haematol. 66, 244-250. (Pubitemid 12239383)
33. Chan, J.C., Chim, C.S., Ooi, C.G., Cheung, B., Liang, R., Chan, T.K., and Chan, V. (2006) Use of the oral chelator deferiprone in the treatment of iron overload in patients with Hb H disease. Br. J. Haematol. 133, 198-205.
34. Chim, C.S., Chan, V., and Todd, D. (1998) Hemosiderosis with diabetes mellitus in untransfused Hemoglobin H disease. Am. J. Hematol. 57, 160-163. (Pubitemid 28096540)
35. Galanello, R., Aru, B., Dessi, C., Addis, M., Paglietti, E., Melis, M.A., Cocco, S., Massa, P., Giagu, N., Barella, S., et al. (1992) HbH disease in Sardinia: molecular, hematological and clinical aspects. Acta Haematol. 88, 1-6.
36. Vaeusorn, O., Fucharoen, S., and Wasi, P. (1988) A study of thalassemia associated with pregnancy. Birth Defects Orig. Artic. Ser. 23, 295-299.
37. Vogiatzi, M.G., Macklin, E.A., Fung, E.B., Vichinsky, E., Olivieri, N., Kwiatkowski, J., Cohen, A., Neufeld, E., and Giardina, P.J. (2006) Prevalence of fractures among the Thalassemia syndromes in North America. Bone 38, 571-575.
38. Viprakasit, V., Veerakul, G., Sanpakit, K., Pongtanakul, B., Chinchang, W., and Tanphaichitr, V.S. (2004) Acute haemolytic crisis in a Thai patient with homozygous haemoglobin Constant Spring (Hb CS/CS): a case report. Ann. Trop. Paediatr. 24, 323-328. (Pubitemid 40045362)
39. Charoenkwan, P., Sirichotiyakul, S., Chanprapaph, P., Tongprasert, F., Taweephol, R., Sae-Tung, R., and Sanguansermsri, T. (2006) Anemia and hydrops in a fetus with homozygous hemoglobin constant spring. J. Pediatr. Hematol. Oncol. 28, 827-830. (Pubitemid 44967679)
40. Hunt, D.M., Higgs, D.R., Winichagoon, P., Clegg, J.B., and Weatherall, D.J. (1982) Haemoglobin Constant Spring has an unstable alpha chain messenger RNA. Br. J. Haematol. 51, 405-413. (Pubitemid 12045314)
41. Styles, L.A., Foote, D.H., Kleman, K.M., et al. (1997) Hemoglobin H-Constant Spring Disease: an under recognized, severe form of a-thalassemia. Int. J. Pediatr. Hematol. Oncol. 4, 69-74.
42. Li, D., Liao, C., and Li, J. (2007) Misdiagnosis of Hb constant spring (alpha142, Term-->Gln, TAA-->CAA in alpha2) in a Hb H (beta4) disease child. Hemoglobin 31, 105-108.
43. Lorey, F. (2000) Asian immigration and public health in California: thalassemia in newborns in California. J. Pediatr. Hematol. Oncol. 22, 564-566.
44. Lorey, F., Charoenkwan, P., Witkowska, H.E., Lafferty, J., Patterson, M., Eng, B., Waye, J.S., Finklestein, J.Z., and Chui, D.H. (2001) Hb H hydrops foetalis syndrome: a case report and review of literature. Br. J. Haematol. 115, 72-78. (Pubitemid 32995097)
45. Chan, V., Chan, T.K., Liang, S.T., Ghosh, A., Kan, Y.W., and Todd, D. (1985) Hydrops fetalis due to an unusual form of Hb H disease. Blood 66, 224-228. (Pubitemid 15004808)
46. Chan, V., Chan, V.W., Tang, M., Lau, K., Todd, D., and Chan, T.K. (1997) Molecular defects in Hb H hydrops fetalis. Br. J. Haematol. 96, 224-228.
47. Suwanrath-Kengpol, C., Kor-anantakul, O., Suntharasaj, T., and Leetanaporn, R. (2005) Etiology and outcome of non-immune hydrops fetalis in southern Thailand. Gynecol. Obstet. Invest. 59, 134-137. (Pubitemid 40591476)
48. Liao, C., Wei, J., Li, Q., Li, J., Li, L., and Li, D. (2007) Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China. Fetal Diagn. Ther. 22, 302-305. (Pubitemid 46920092)
49. Singer, S.T., Styles, L., Bojanowski, J., Quirolo, K., Foote, D., and Vichinsky, E.P. (2000) Changing outcome of homozygous alpha-thalassemia: cautious optimism. J. Pediatr. Hematol. Oncol. 22, 539-542. (Pubitemid 33599830)
50. Chan, V., Yip, B., Lam, Y.H., Tse, H.Y., Wong, H.S., and Chan, T.K. (2001) Quantitative polymerase chain reaction for the rapid prenatal diagnosis of homozygous alpha-thalassaemia (Hb Barts hydrops fetalis). Br. J. Haematol. 115, 341-346. (Pubitemid 34203500)
51. Phupong, V. (2006) An increase of the cardiothoracic ratio leads to a diagnosis of Bart's hydrops. J. Med. Assoc. Thai. 89, 509-512.
52. Leung, K.Y., Liao, C., Li, Q.M., Ma, S.Y., Tang, M.H., Lee, C.P., Chan, V., and Lam, Y.H. (2006) A new strategy for prenatal diagnosis of homozygous alpha(0)-thalassemia. Ultrasound Obstet. Gynecol. 28, 173-177. (Pubitemid 44265172)
53. Liao, C., Li, Q., Wei, J., Feng, Q., Li, J., Huang, Y., and Li, D. (2007) Prenatal control of Hb Bart's disease in southern China. Hemoglobin 31, 471-475. (Pubitemid 350125636)
54. Lau, E.T., Kwok, Y.K., Luo, H.Y., Leung, K.Y., Lee, C.P., Lam, Y.H., Chui, D.H., and Tang, M.H. (2005) Simple non-invasive prenatal detection of Hb Bart's disease by analysis of fetal erythrocytes in maternal blood. Prenat. Diagn. 25, 123-128.
55. Chan, V., Ng, E.H., Yam, I., Yeung, W.S., Ho, P.C., and Chan, T.K. (2006) Experience in preimplantation genetic diagnosis for exclusion of homozygous alpha degrees thalassemia. Prenat. Diagn. 26, 1029-1036. (Pubitemid 44804686)
56. Thornley, I., Lehmann, L., Ferguson, W.S., Davis, I., Forman, E.N., and Guinan, E.C. (2003) Homozygous alphathalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation. Bone Marrow Transplant. 32, 341-342. (Pubitemid 36927089)
57. Lee, S.Y., Chow, C.B., Li, C.K., and Chiu, M.C. (2007) Outcome of intensive care of homozygous alphathalassaemia without prior intra-uterine therapy. J. Paediatr. Child Health 43, 546-550.
58. Lucke, T., Pfister, S., and Durken, M. (2005) Neurodevelopmental outcome and haematological course of a long-time survivor with homozygous alpha-thalassaemia: case report and review of the literature. Acta Paediatr. 94, 1330-1333. (Pubitemid 41510633)
59. Sohan, K., Billington, M., Pamphilon, D., Goulden, N., and Kyle, P. (2002) Normal growth and development following in utero diagnosis and treatment of homozygous alpha-thalassaemia. BJOG 109, 1308-1310. (Pubitemid 36167828)
60. Carr, S., Rubin, L., Dixon, D., Star, J., and Dailey, J. (1995) Intrauterine therapy for homozygous alpha-thalassemia. Obstet. Gynecol. 85, 876-879.
61. Hayward, A., Ambruso, D., Battaglia, F., Donlon, T., Eddelman, K., Giller, R., Hobbins, J., Hsia, Y.E., Quinones, R., Shpall, E., Trachtenberg, E., and Giardina, P. (1998) Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn. Ther. 13, 8-14.
62. Harper, D.C., Swingle, H.M., Weiner, C.P., Bonthius, D.J., Aylward, G.P., and Widness, J.A. (2006) Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am. J. Obstet. Gynecol. 195, 192-200.
63. Sorour, Y., Heppinstall, S., Porter, N., Wilson, G.A., Goodeve, A.C., Rees, D., and Wright, J. (2007) Is routine molecular screening for common alpha-thalassaemia deletions necessary as part of an antenatal screening programme? J. Med. Screen. 14, 60-61. (Pubitemid 47067757)
64. Weatherall, D.J. (1998) Thalassemia in the next millennium. Keynote address. Ann. N. Y. Acad. Sci. 850, 1-9.
65. Lorey, F., Cunningham, G., Vichinsky, E.P., Lubin, B.H., Witkowska, H.E., Matsunaga, A., Azimi, M., Sherwin, J., Eastman, J., Farina, F., Waye, J.S., and Chui, D.H. (2001) Universal newborn screening for Hb H disease in California. Genet. Test. 5, 93-100. (Pubitemid 32801824)
66. Aslanian, S., Azimi, M., Noble, J., and Hoppe, C. (2007) Application of flow cytometry-based genotyping for rapid detection of hemoglobin variants. Int. J. Lab. Hematol. 29, 284-291. (Pubitemid 47041485)